Extract from the Register of European Patents

EP About this file: EP2162154

EP2162154 - COLORED ESMOLOL CONCENTRATE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.04.2012
Database last updated on 18.03.2026
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Baxter International Inc.
One Baxter Parkway DF2-2W
Deerfield, IL 60015 / US
For all designated states
Baxter Healthcare S.A.
Thurgauerstrasse 130
8152 Glattpark (Opfikon) / CH
[2010/11]
Inventor(s)01 / TIWARI, Deepak
53 Vones Lane
Raritan, New Jersey 08869 / US
02 / OWOO, George
208 Harding Avenue
North Plainfield, New Jersey 07063 / US
03 / NAYAK, Rekha
13 Arlene Court
Monmouth Junction, New Jersey 08852 / US
04 / BURHOP, Kenneth E
11009 Sandpiper Court
Spring Grove, Illinois 60081 / US
 [2010/11]
Representative(s)Dee, Ian Mark
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2010/11]Dee, Ian Mark
Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham
NG1 5DD / GB
Application number, filing date07813699.102.08.2007
[2010/11]
WO2007US75069
Priority number, dateUS2007075208622.05.2007         Original published format: US 752086
[2010/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008143682
Date:27.11.2008
Language:EN
[2008/48]
Type: A1 Application with search report 
No.:EP2162154
Date:17.03.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 27.11.2008 takes the place of the publication of the European patent application.
[2010/11]
Type: B1 Patent specification 
No.:EP2162154
Date:15.06.2011
Language:EN
[2011/24]
Search report(s)International search report - published on:EP27.11.2008
ClassificationIPC:A61K47/22, A61K9/00
[2010/11]
CPC:
A61K31/24 (EP,KR,US); A61K31/215 (KR); A61K9/0019 (EP,US);
A61K9/08 (KR); A61P43/00 (EP); A61P9/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/11]
TitleGerman:FARBIGE ESMOLOL-KONZENTRATE[2010/11]
English:COLORED ESMOLOL CONCENTRATE[2010/11]
French:CONCENTRÉ D'ESMOLOL COLORÉ[2010/11]
Entry into regional phase21.12.2009National basic fee paid 
21.12.2009Designation fee(s) paid 
21.12.2009Examination fee paid 
Examination procedure21.12.2009Examination requested  [2010/11]
15.02.2010Amendment by applicant (claims and/or description)
16.08.2010Communication of intention to grant the patent
15.12.2010Fee for grant paid
15.12.2010Fee for publishing/printing paid
24.02.2011Despatch of a communication from the examining division (Time limit: M04)
14.03.2011Reply to a communication from the examining division
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.08.2010
Opposition(s)16.03.2012No opposition filed within time limit [2012/21]
Fees paidRenewal fee
26.10.2009Renewal fee patent year 03
25.08.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY15.06.2011
CZ15.06.2011
DK15.06.2011
EE15.06.2011
FI15.06.2011
HU15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
TR15.06.2011
LU02.08.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
BG15.09.2011
GR16.09.2011
ES26.09.2011
IS15.10.2011
PT17.10.2011
[2013/45]
Former [2013/44]CY15.06.2011
CZ15.06.2011
DK15.06.2011
EE15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
TR15.06.2011
LU02.08.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
BG15.09.2011
GR16.09.2011
ES26.09.2011
IS15.10.2011
PT17.10.2011
Former [2013/29]CY15.06.2011
CZ15.06.2011
DK15.06.2011
EE15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
LU02.08.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
BG15.09.2011
GR16.09.2011
ES26.09.2011
IS15.10.2011
PT17.10.2011
Former [2013/25]CY15.06.2011
CZ15.06.2011
DK15.06.2011
EE15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
LU02.08.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR16.09.2011
ES26.09.2011
IS15.10.2011
PT17.10.2011
Former [2013/22]CY15.06.2011
CZ15.06.2011
DK15.06.2011
EE15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR16.09.2011
ES26.09.2011
IS15.10.2011
PT17.10.2011
Former [2012/31]CY15.06.2011
CZ15.06.2011
DK15.06.2011
EE15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR16.09.2011
IS15.10.2011
PT17.10.2011
Former [2012/20]CY15.06.2011
CZ15.06.2011
EE15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
CH31.08.2011
LI31.08.2011
MC31.08.2011
GR16.09.2011
IS15.10.2011
PT17.10.2011
Former [2012/18]CY15.06.2011
CZ15.06.2011
EE15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
MC31.08.2011
GR16.09.2011
IS15.10.2011
PT17.10.2011
Former [2012/12]CY15.06.2011
CZ15.06.2011
EE15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
PL15.06.2011
RO15.06.2011
SE15.06.2011
SI15.06.2011
SK15.06.2011
GR16.09.2011
IS15.10.2011
PT17.10.2011
Former [2012/05]CY15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
MT15.06.2011
NL15.06.2011
SE15.06.2011
SI15.06.2011
GR16.09.2011
Former [2012/02]CY15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
NL15.06.2011
SE15.06.2011
SI15.06.2011
GR16.09.2011
Former [2011/50]CY15.06.2011
FI15.06.2011
LT15.06.2011
LV15.06.2011
SE15.06.2011
SI15.06.2011
GR16.09.2011
Former [2011/49]CY15.06.2011
FI15.06.2011
LT15.06.2011
SE15.06.2011
GR16.09.2011
Former [2011/48]LT15.06.2011
SE15.06.2011
Cited inInternational search[Y]   DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2002, VASDEV GURINDER ET AL: "Analysis of Systems Failure Leading to Medication Errors: The role of Sentinel Events for Anesthesiologists.", XP002475538, Database accession no. PREV200300100453 [Y] 1-19 * abstract *
 [Y]   ANESTHESIOLOGY ABSTRACTS OF SCIENTIFIC PAPERS ANNUAL MEETING, no. 2002, 2002, 2002 ANNUAL MEETING OF THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS; ORLANDO, FL, USA; OCTOBER 12-16, 2002, pages Abstract No. A - 1153 URL
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.